Veeva Systems announced that 40 contract research organizations (CROs) selected Veeva Vault CTMS to deliver faster and more efficient trials to sponsors, which includes four of the top six global CROs. These global leaders Labcorp Drug Development, Parexel, PPD clinical research business of Thermo Fisher Scientific Inc., and Syneos Health are unifying clinical on a single platform as they expand their use of Veeva Vault Clinical Suite from Vault eTMF to now include Vault CTMS. Also selected by more than 120 sponsors, including 9 of the top 20 pharmaceutical companies, Vault CTMS has fast become the solution for clinical trial management. As CROs increasingly standardize on Vault CTMS, they can support sponsor preference for Veeva Vault while modernizing study operations for more efficient execution.

Vault CTMS provides a complete view of trial metrics so CROs can better manage study performance and increase transparency to sponsors. Sponsors and CROs using Vault CTMS work on a consistent industry standard platform that makes it easier to collaborate and share study information for real-time visibility across the study portfolio.